ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
39 056,39
0,44%
DAX
18 498,38
0,32%
Brent Oil
83,635
0,09%
Bitcoin
61 283,78
0,16%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Inspira Technologies Oxy B H N Ltd (IINN)

  7. Inspira Technologies Oxy B H N Ltd (IINN) Actualités

IINN Inspira Technologies Oxy B H N Ltd

2,20
-0,01 (-0,45%)
Après les heures de négociation
Dernière mise à jour : 01:50:09
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Inspira Technologies Oxy B H N Ltd IINN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,01 -0,45% 2,20 01:50:09
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,20 1,91 2,20 2,09 2,21
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202415:18PRNUSInspira™ Announces Start of Production of the INSPIRA™..
25/4/202414:00PRNUSInspira™ Receives CSA Certification of Compliance to U.S...
16/4/202414:42PRNUSInspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device..
10/4/202414:24PRNUSInspira™ and Ennocure In Vitro Study Results Show 100%..
03/4/202414:30PRNUSInspira™ Announces Program to Pioneer the Applicable Use of..
01/4/202414:00PRNUSInspira™ Announces $1.65 Million Registered Direct Offering..
25/3/202414:20PRNUSInspira™ Technologies Reports Full Year 2023 Financial..
18/3/202412:00PRNUSInspira™ Announces AMAR Regulatory Submission of the..
12/3/202413:00PRNUSInspira™ Releases New Data Demonstrating Superiority of its..
08/3/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202415:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202415:20PRNUSInspira™ Announces Plans to Report the Primary Results for a..
27/2/202413:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202413:02PRNUSInspira™ To Host Conference Call to Discuss Investor..
27/2/202413:00PRNUSInspira™ Announces Breakthrough Update: Nears First FDA..
22/2/202415:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202413:00PRNUSInspira™ introduces high-end platform for bio-mimicking..
14/2/202415:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202413:30PRNUSInspira™ Receives First Ever U.S. Patent Approval for an..
12/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/2/202415:00PRNUSInspira™ Technologies Collaborates with a Leading Israeli..
30/1/202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202414:30PRNUSInspira™ Technologies Signs Strategic Agreement to Enter..
09/1/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202414:30PRNUSInspira™ Announces Plans to Launch and Target Single-Use..
02/1/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202414:30PRNUSInspira™ Technologies Signs Letter of Intent with..
28/12/202322:01PRNUSInspira™ Technologies Closes on $3.88 Million Registered..
28/12/202315:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/12/202322:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202320:16PRNUSInspira Announces $3.88 Million Registered Direct Offering
26/12/202314:45PRNUSInspira™ Announces 95% Accuracy Results for HYLA™ Blood..
18/12/202314:30PRNUSInspira Technologies to Participate in J.P. Morgan..
11/12/202315:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202315:00PRNUSIn Preparation for FDA Clearance and Device Deployment,..
29/11/202315:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202315:02PRNUSInspira Collaborates with Ennocure for development of a..
22/11/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202315:40PRNUSInspira™ Technologies Reports Third Quarter 2023 Financial..
16/11/202315:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202313:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202315:02PRNUSInspira™ Announces Israeli Innovation Authority Grant for..
25/10/202322:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/10/202314:30PRNUSInspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical..
25/10/202313:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NASDAQ
IINN
Inspira Technologies Oxy...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés